Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Eisai is a Japanese pharmaceutical company dedicated to the research, development, and global marketing of innovative medicines. With a focus on neurology and oncology, Eisai enhances patient health and quality of life through scientific advancements and patient-centric therapies.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Eisai is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Eisai last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 64.71 JPY.
Across its last 4 earnings reports, Eisai stock moved by ±1.5% on average the following day. The largest reaction was -4.2% on 11/05/2025; 3 of 4 reactions were positive.
Eisai has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.